The results show that AF-MSC-hypoCM improves the wound-healing effect in vivo through fibronectin-enhanced cell migration and both the TGF-β/SMAD2 and PI3K/AKT signal pathways. This evidence concerns the gene TGFB1 and atrial fibrillation.